Department of Cardiology, Helios Klinikum Pirna, Pirna, Germany.
Department of Cardiology, TU Dresden Campus Chemnitz-MEDiC, Klinikum Chemnitz, Chemnitz, Germany.
Clin Cardiol. 2024 Aug;47(8):e24327. doi: 10.1002/clc.24327.
The establishment of venous access is one of the driving factors for complications during implantation of pacemakers and defibrillators (cardiac implantable electronic devices [CIED]). Recently, a novel approach of accessing the cephalic vein for CIED by cephalic vein puncture (CVP) using a modified Seldinger technique has been described, promising high success rates and simplified handling with steeper learning curves. In this single-center registry, we analyzed the safety and efficiency of CVP to SVP access after defining CVP as the primary access route in our center.
A total of 229 consecutive patients receiving a CIED were included in the registry. Sixty-one patients were implanted by primary or bail-out SVP; 168 patients received primary cephalic preparation and CVP was performed when possible, using a hydrophilic transradial sheath.
Implantation of at least one lead via CVP was successful in 151 of 168 patients (90%), and implantation of all leads was possible in 122 of 168 patients (72.6%). Total implantation times and fluoroscopy times and doses did not differ between CVP and SVP implantations. Pneumothorax occurred in 0/122 patients implanted via CVP alone, but 8/107 (7.5%) patients received at least one lead via SVP.
Our data confirms high success rates of the CVP for CIED implantation. Moreover, this method can be used without significantly prolonging the total procedure time or applying fluoroscopy dose compared to the highly efficient SVP while showing lower overall complication rates.
建立静脉通路是植入起搏器和除颤器(心脏植入式电子设备 [CIED])过程中发生并发症的驱动因素之一。最近,一种通过改良 Seldinger 技术进行头静脉穿刺(CVP)来获取头静脉以用于 CIED 的新方法已经被描述,该方法有望实现高成功率,并简化操作,学习曲线更陡峭。在本单中心注册研究中,我们分析了 CVP 到 SVP 通路的安全性和效率,该研究将 CVP 定义为我们中心的主要通路。
该注册研究共纳入 229 例连续接受 CIED 治疗的患者。61 例患者通过原发性或紧急 SVP 进行植入;168 例患者接受了原发性头静脉准备,并尽可能使用亲水经桡动脉鞘进行 CVP。
在 168 例患者中,有 151 例(90%)通过 CVP 成功植入至少一根导线,122 例(72.6%)所有导线均可通过 CVP 植入。CVP 和 SVP 植入的植入总时间、透视时间和剂量无差异。单独通过 CVP 植入的患者中,气胸的发生率为 0/122 例,但通过 SVP 植入的患者中有 8/107 例(7.5%)至少植入了一根导线。
我们的数据证实了 CVP 用于 CIED 植入的高成功率。此外,与高效的 SVP 相比,该方法在不显著延长总手术时间或应用透视剂量的情况下即可使用,同时显示出较低的总并发症发生率。